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OBJECTIVES: Childhood cancer mortality has substantially declined worldwide as a result of significant advances
in global cancer care. Because limited information is available in Brazil, we analyzed trends in childhood cancer
mortality in five Brazilian regions over 29 years.
METHODS: Data from children 0-14 years old were extracted from the Health Mortality Information System for
1979 through 2008. Age-adjusted mortality rates, crude mortality rates, and age-specific mortality rates by
geographic region of Brazil and for the entire country were analyzed for all cancers and leukemia. Mortality
trends were evaluated for all childhood cancers and leukemia using joinpoint regression.
RESULTS: Mortality declined significantly for the entire period (1979-2008) for children with leukemia.
Childhood cancer mortality rates declined in the South and Southeast, remained stable in the Middle West, and
increased in the North and Northeast. Although the mortality rates did not unilaterally decrease in all regions,
the age-adjusted mortality rates were relatively similar among the five Brazilian regions from 2006-2008.
CONCLUSIONS: Childhood cancer mortality declined 1.2 to 1.6% per year in the South and Southeast regions.
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& INTRODUCTION
Although mortality rates due to childhood leukemia and
other cancers have substantially declined in several parts of
the world, significant differences in specific patterns have
been observed in certain regions (1-3). Favorable trends are
less pronounced in less-developed regions, including Latin
America (1,4,5). Cancer mortality statistics in low- and
middle-income countries suffer from predictable sources of
error, including inaccurate death certificates, misdiagnosis,
and underreporting (1,5,6). Brazil demonstrates great
heterogeneity in cultural and socioeconomic patterns across
five geographic regions. In the 1970s, death certification
quality, completeness, and reporting of ill-defined deaths
differed among the five regions, with adequate coverage in
the Southeast and South and poor coverage in the North and
Northeast. National government agencies have exerted
continuous efforts to improve death certification quality,
and the proportion of ill-defined deaths has achieved
acceptable quality in all regions since 2006 (6).
The objectives of this study were to describe childhood
cancer and leukemia mortality in the five geographic
regions of Brazil and to evaluate trends in mortality over
29 years (1979-2008) using joinpoint regression analysis (7).
& METHODS
Brazil was divided into five geographic regions: North,
Northeast, Southeast, South, and Middle West (Table 1). Data
from children 0-14 years old were extracted from the databases
of the Brazilian Health Mortality Information System for the
years 1979 to 2008. (http://www.datasus.gov.br) The age
range of 0-14 years was chosen based on the criteria used by
SEER (Surveillance, Epidemiology and End results; www.
http://seer.cancer.gov.) and IARC (International Agency for
Research in Cancer; http://www.iarc.fr) in their international
monographs.
Death-related information was organized according to
gender, age group, state (place of residence), and cause of
death (malignant neoplasm according to the International
Classification of Diseases and Related Health Problems,
ICD-9 (1979-95) and ICD-10 (1996-2008)) (8,9). The analysis
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included examination of the number of deaths, age-adjusted
mortality rates (AAMRs), crude mortality rates, and age-
specific mortality rates (ASMRs) by geographic region and
for the entire country. AAMRs were calculated according to
all cancer deaths and leukemia, gender, and time period via
a direct method using the proposed world population in age
groups less than 14 years old (10). For ASMRs, gender and
time period were calculated by age groups defined as less
than 1, 1-4, 5-9, and 10-14 years. To identify significant
changes in the trends for all childhood cancers and
leukemia, we performed joinpoint regression analysis to
establish the best cut-point period for measuring the trends
described elsewhere (www.srab.cancer.gov/joinpoint) (7).
Significance was determined with the Monte Carlo
Permutation method. The models either incorporated the
estimated variation for each point when the responses were
AAMRs or used a Poisson model of variation. In addition,
the models could also be linear on the log of the response to
calculate the annual percentage rate change. Because the
proportion of ill-defined deaths achieved a quality control
standard (less than 10% in all five Brazilian regions) in 2006-
2008, the age-specific mortality rate was analyzed for this
period (Supplemental Table 1).
& RESULTS
Figure 1 depicts the trends in AAMR from all childhood
cancers and from leukemia for 1979-2008 in the entire
country and according to the five major regions. The
AAMRs showed a trend toward stability in the entire
country (36.91 deaths per million in 1979 and 39.83 deaths
per million in 2008) for all cancers and a slight decrease for
leukemia (14.33 deaths per million in 1979 and 13.83 deaths
per million in 2008). The North and Northeast regions
experienced increased mortality rates, while the rates
decreased in the South and Southeast and were stable in
the Middle West (Figure 1).
The joinpoint analysis of the AAMR (ages 0-14 years) for
all childhood cancers and leukemia according to gender and
region is shown in Table 2. Mortality from all childhood
cancers from 1979-2008 demonstrated a slight but significant
decline in boys of almost 0.5% per year (average annual
percent change (AAPC) =20.34) and was stable in girls
(AAPC =20.03). In the North and Northeast regions, there
was a significant increase of 2 to 3% per year (boys and
girls). In the Middle-West, South, and Southeast, the
mortality rate decreased significantly from 0.5 to 1.5% per
year for boys and girls (Table 2).
A significant decline in leukemia of about 1% per year
was observed in both genders (AAPC =20.98 and -0.81 for
boys and girls, respectively). Mortality due to childhood
cancers declined over the entire period, with AAPCs of -1.41
for boys and -1.21 for girls in the Southeast and AAPCs of -
1.57 for boys and -1.21 for girls in the South. The North
(AAPC = +2.09 boys, +2.07 girls) and Northeast
(AAPC = +2.52 boys, +2.80 girls) regions experienced sig-
nificant increases of 2% per year in mortality rates. For
leukemia, the same pattern of mortality decline occurred in
the South and Southeast, but the mortality rates increased in
the North and Northeast. A stable mortality rate was
recorded in the Middle-West region except for boys, who
experienced a significant decline for leukemia (AAPC -1.41).
Table 3 contains the AAMR data for all childhood cancers
and for leukemia for 2006-2008. Similar mortality rates were
recorded for all cancers among the five geographic regions
of Brazil. The only difference was observed in some age
groups among the regions; higher mortality rates were
reported for the 0-year and 1-4-year groups in the Northeast
and Middle West regions. Leukemia AAMRs were higher
for boys in the North region (data not shown). During the
first year of life, lower mortality rates were observed in the
Southeast, while the mortality rate in the North was the
highest.
& DISCUSSION
Childhood cancer mortality rates have decreased signifi-
cantly in recent decades and have remained fairly constant
since 1997 (11). Less-developed countries, including many
countries in South America, have experienced less favorable
outcomes. However, a major limitation of mortality rate
analyses is the availability of high-quality vital statistics
(1,12). Mortality rates should be analyzed with caution
because they are affected by the quality of diagnosis data,
quality of death certification, socioeconomic characteristics,
and medical facilities specializing in pediatric oncology.
Since 1988, a complex health system (the Unified Health
System) has been under development in Brazil and has
substantially improved access to health care. Infant mortal-
ity decreased from 114 per 1,000 live births in 1970 to 19.3
per 1,000 live births in 2007 (13). Although the disparity is
decreasing, geographic and social inequalities still exist; in
Table 1 - Socioeconomic characteristics of Brazil and its regions.
Brazil North Northeast Middle West Southeast South
Total Population (2008) 189,612,814 15,142,684 53,088,499 13,695,944 80,187,717 27,497,970
Population 0-14 years (2008) 49,476,645 4,956,629 15,375,104 3,623,141 19,056,866 6,464,905
GNP* per capita 14,056.27 8,706.43 6,663.58 17,457.89 18,615.63 16,020.11
Income less than 1/4 minimum
wage per family (%)
11.33 15.49 23.10 6.80 5.50 4.84
Illiteracy Rate (% population 15 and
more years old)
Male Population 10.16 11.21 21.06 8.24 5.25 5.00
Female Population 9.78 10.26 17.89 8.12 6.32 5.87
Total 9.96 10.73 19.41 8.18 5.81 5.45
Under 5 year Mortality Rate (2007) 24.07 26.32 35.2 20.18 17.08 15.11
Source: MS/SVS/DASIS/CGIAE/Indicators and Health Information (IDB), 2009. North Region: Acre, Amapa´, Amazonas, Para´, Rondoˆnia, Roraima, and
Tocantins. Northeast Region: Alagoas, Bahia, Ceara´, Maranha˜o, Paraı´ba, Pernambuco, Piauı´, Rio Grande do Norte, and Sergipe. Southeast Region: Espı´rito
Santo, Minas Gerais, Rio de Janeiro, and Sa˜o Paulo. South Region: Parana´, Rio Grande do Sul, and Santa Catarina. Middle West Region: Brasilia, Goia´s,
Mato Grosso, and Mato Grosso do Sul. GNP: Gross National Product.
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the Northeast region, the infant mortality rate is 2.24 times
higher than that in the South region (14). Pneumonia
mortality for children aged 4 years and younger decreased
significantly from 1991 to 2007 in all regions of Brazil, but
the smallest decrease occurred in the North and Northeast
regions in children younger than one year (15). Several
initiatives have contributed to this decline, including
promotion of breastfeeding, oral rehydration, and immuni-
zations. Malnourishment in children less than 5 years old
has significantly decreased in the past 17 years, from 7.1% to
1.8% for low-weight children and 19.6% to 6.8% for low-
heightchildren (16). Vaccination reached universal coverage
Figure 1 - Trends in age-standardized 0-14 years mortality rates for all childhood cancers and leukemias in Brazil and its 5 different regions.
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in the 1980s and is provided by the government.
Poliomyelitis was eliminated from Brazil in 1989, and the
last autochthonous case of measles occurred in 1999 (14).
Awareness of childhood cancer has increased since the
1980s, and several government and nongovernment initia-
tives have been implemented. In 1997, the Brazilian Ministry
of Health and the Bank of Brazil Foundation together with the
Brazilian Pediatric Oncology Society (SOBOPE) developed a
program to promote early recognition of childhood cancer
with better diagnostic procedures, better adherence to
treatment protocols, and extensive pediatric oncology train-
ing. There has been a clear improvement in recognition and
classification of leukemia with this approach (17). An early
diagnosis program supported by a nongovernment organiza-
tion was implemented in 2008. Its main objective is to train
health family teams in the early recognition of signs and
symptoms of cancer and to contribute to the organization of a
network for referrals in various regions of the country.
Despite heterogeneity among the regions in Brazil, the
AAMRs were similar from 2006-2008, and over 29 years, a
slightly decreasing trend was observed in the Southeast and
South regions. Several isolated institutions have signifi-
cantly improved the treatment of childhood cancer.
Following adherence to treatment protocols, children
treated in specialized centers experienced a dramatic
improvement in survival. In Recife, a city in the
Northeast, a significant improvement in survival for
children with acute lymphoblastic leukemia was reported
following the establishment of a twinning program (16). The
Pediatric Department of the Hospital A. C. Camargo in Sa˜o
Paulo, an isolated specialized cancer center, analyzed 3,827
children and adolescents 0-18 years old with cancer and
leukemia and reported a significant decrease in mortality
rates from 1975-1999 (from 81% to 33%; p,0.001) (18). The
Instituto Nacional de Caˆncer in Rio de Janeiro assessed 163
patients with rhabdomyosarcoma over 18 years and
reported that 39.3% of the patients had metastatic disease
at diagnosis, and the overall survival rates for clinical
groups I+II, III, and IV were 79.6%, 68.3%, and 17.8%,
respectively (p,0.001). Low weight (body mass index ,10th
percentile at diagnosis) emerged as an independent adverse
prognostic factor (19).
Outcomes in children with cancer are much better
following treatment by a multidisciplinary team in a
pediatric cancer center (20,21). SOBOPE has established
cooperative groups with planned clinical trials, which may
potentially impact survival and mortality rates. The
Brazilian Cooperative Group for Treatment of Childhood
Acute Lymphocytic Leukemia (ALL) reported a 5-year
overall survival of 92.5% among 544 children with low-risk
ALL in several Brazilian centers (22). A recent study from
the Osteosarcoma Brazilian Group indicated an overall
survival of 60% for patients with nonmetastatic disease; a
large tumor size was observed in 43% of the cases and was
not associated with longer lag time (23). After the introduc-
tion of a standard protocol, the five-year overall survival for
high-risk patients with germ-cell tumors was 83.3%, which
is particularly relevant to the treatment protocols in small
institutions with limited experience in the treatment of this
rare disease (24).
An impressive decrease in mortality from ill-defined
causes in all regions was observed from 1979-2008. The
Mortality Information System was created in 1975 in Brazil,
and since that time, steps have been taken to improve theT
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quality of mortality data. In 2005, a thorough and careful
supervision effort was performed to improve the quality of
death certification in the Northeast and North. Fewer than
10% of ill-defined causes were recorded in the Southeast
since 1979. This benchmark was reached in the South and
Middle West regions in 1988 and in the Northeast and
North in 2006. This change may underlie the documented
increased cancer mortality rates in the North and Northeast
regions. A consistent decrease in mortality rates due to
childhood leukemia in Brazil and greater decreases in the
South and Southeast were observed from 1980 to 2002.
These decreases included a higher mortality rate for boys
compared with girls, as confirmed by our data for 2006 to
2008. The leukemia mortality rate in the state of Rio de
Janeiro declined during 1980 and 2006 and was also more
pronounced in boys (25).
Correlations have been noted between social inequality
and changes in mortality, with more pronounced decreases
in mortality in the Brazilian regions with better socio-
economic conditions (5). Socioeconomic status plays a key
role in health care due to factors such as access to health
care services and specialized centers, availability of
hospital beds, physician density, adherence and abandon-
ment of treatment, early diagnosis, and clinician-parent
communication. Despite improvements in childhood can-
cer survival in specialized centers, these improvements did
not translate into a significant decline in mortality in Brazil
or its regions. Socioeconomic inequalities may explain the
divergence between hospital data and population-based
registry data (26,27). According to a population-based
registry study in Sa˜o Paulo, the probability of survival for
60 months was 40% for patients 0-14 years of age with
cancer (27).
The year 2006 may be considered a starting point for
regional monitoring because quality control standards were
achieved in the five geographic regions of Brazil and ill-
defined deaths represented less than 10% of all deaths.
During this period, the mortality rates were similar among
all the regions, regardless of socioeconomic characteristics;
the curves for the North and Northeast may still be
climbing, or competitive risks of death may be masking
mortality rates from cancer. The assessment period here was
short, and longer periods will be necessary to evaluate
comprehensive trends.
These observations need to be explored in further studies,
including population-based cancer survival studies.
Surveillance of childhood cancer mortality should be well
maintained as a major resource for health planning and as a
base to monitor the effectiveness of implemented strategies.
Substantial challenges remain, and socioeconomic issues
and adoption of integrated treatment strategies should be
addressed to improve mortality rates due to childhood
cancers in Brazil. This study is consistent with previous
studies from Brazil showing that the magnitude of cancer
mortality rates is generally lower than that observed in
developed countries (28-30).
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Supplemental Table 1 - Percentage of ill-defined mortality in children (0-14 years old) in Brazil and its regions (1979-
2008).
Years BRAZIL NORTH NORTHEAST MIDDLE-WEST SOUTHEAST SOUTH
1979 24.4 25.0 53.1 13.4 6.4 15.0
1980 26.4 25.5 54.6 12.5 5.7 14.5
1981 24.7 21.9 52.1 12.9 4.7 14.6
1982 22.4 23.0 47.7 12.5 4.6 13.0
1983 23.8 23.6 47.3 13.3 4.9 12.8
1984 25.6 26.1 50.1 12.8 4.6 12.6
1985 23.9 24.7 45.6 11.9 7.5 11.9
1986 24.2 26.2 45.8 12.7 7.1 11.1
1987 23.5 25.4 45.1 12.6 6.6 11.2
1988 22.4 25.0 44.7 10.9 5.8 10.3
1989 20.7 24.3 41.6 9.0 5.7 10.8
1990 19.7 27.9 40.2 9.4 5.7 10.3
1991 19.6 25.6 39.3 9.2 6.7 8.5
1992 18.5 24.1 36.3 8.4 7.0 8.3
1993 19.2 23.6 38.0 8.3 7.0 7.8
1994 16.9 22.7 32.9 8.2 7.0 7.9
1995 14.3 18.3 27.8 7.4 6.3 7.3
1996 12.9 17.5 25.5 6.1 5.9 6.3
1997 11.8 17.3 23.1 5.1 5.2 5.1
1998 12.7 16.9 23.0 6.4 5.8 6.3
1999 12.2 15.8 21.2 5.2 6.6 5.3
2000 12.5 16.8 21.3 4.4 6.4 4.8
2001 10.8 14.6 17.7 3.8 5.8 4.6
2002 9.9 15.5 15.2 3.6 5.2 4.5
2003 9.4 14.8 14.2 3.0 5.2 4.9
2004 8.0 13.6 11.8 3.0 4.6 3.7
2005 6.3 11.3 7.8 3.1 4.5 4.0
2006 5.4 9.8 5.0 3.5 5.0 3.9
2007 4.8 8.9 4.2 2.6 4.6 4.0
2008 4.9 8.4 4.5 3.0 4.7 3.9
Source: MS/SVS/DASIS/CGIAE/Sistema de Informac¸a˜o sobre Mortalidade – SIM.
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